Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:Q86TM3 (
cage
)
29,987
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Lung cancer is the leading cause of
cancer-associated
mortality worldwide. Previous studies have demonstrated that long non-coding RNAs (lncRNAs) serve important roles in diverse biological processes. However, the molecular function and prognostic value of the majority of lncRNAs in non-small cell lung cancer (NSCLC) remain unknown. The present study investigated the expression of the lncRNA
GABPB1
intronic transcript (
GABPB1
-IT1) in NSCLC tissues using publicly available databases. Subsequently, protein-protein interaction (PPI) and co-expression networks were constructed to identify key targets of lncRNA
GABPB1
-IT1. Furthermore, gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis were performed to investigate the potential roles of lncRNA
GABPB1
-IT1. The current study identified that the expression of
GABPB1
-IT1 was significantly downregulated in NSCLC samples compared with normal samples. Furthermore, the expression levels of
GABPB1
-IT1 were lower in high grade NSCLC samples compared with low grade NSCLC samples. Additionally, overexpression of
GABPB1
-IT1 in cancer samples was associated with improved survival of patients with NSCLC.
GABPB1
-IT1 was revealed to be involved in the regulation of cell cycle-associated biological processes, including sister chromatid cohesion, mitotic nuclear division, DNA replication, chromosome segregation, G1/S transition of mitotic cell cycle, mitotic cytokinesis and cell division. Finally, a
GABPB1
-IT1-associated protein-protein interaction network was constructed for NSCLC. To the best of our knowledge, the present study was the first to demonstrate that
GABPB1
-IT1 is associated with the prognosis of NSCLC. The current study provides useful information to assist with the investigation of potential candidate biomarkers for diagnosis, prognosis and drug targets for NSCLC.
...
PMID:Identification of a novel lncRNA GABPB1-IT1 that is downregulated and predicts a poor prognosis in non-small cell lung cancer. 3128 61